샘플 요청 목록

 카트 문의
시장보고서
상품코드
1543999

세계의 뎅기열 검사 시장

Dengue Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 158 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 뎅기열 검사 시장은 2030년까지 7억 4,080만 달러에 달할 전망

2023년에 5억 3,100만 달러로 추정된 세계의 뎅기열 검사 시장은 2030년에는 7억 4,080만 달러에 달하며, 분석 기간인 2023-2030년 CAGR은 4.9%로 성장할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 병원 최종 용도는 CAGR 5.8%를 기록하며, 분석 기간 종료까지 3억 6,780만 달러에 달할 것으로 예측됩니다. 진단 센터 최종 용도 부문의 성장률은 분석 기간 중 CAGR 4.5%로 추정됩니다.

미국 시장은 1억 4,330만 달러로 추정, 중국은 CAGR 8.3%로 성장할 것으로 예측

미국의 뎅기열 검사 시장은 2023년에 1억 4,330만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 1억 6,130만 달러 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 8.3%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.4%와 4.0%로 예측됩니다. 유럽에서는 독일이 CAGR 3.2%로 성장할 것으로 예측됩니다.

세계의 뎅기열 검사 시장 - 주요 동향과 촉진요인 정리

뎅기열이란 무엇이며, 왜 정확한 검사가 중요한가?

뎅기열은 주로 전 세계 열대 및 아열대 기후에서 유행하는 모기 매개 바이러스성 질환으로 공중보건에 큰 위협이 되고 있으며, 4개의 뎅기열 바이러스 혈청형 중 하나에 의해 발생하며, 경미한 발열부터 독감과 같은 심각한 증상까지 다양한 증상이 나타나며, 심한 경우 뎅기출혈열로 발전하여 사망에 달할 수 있습니다. 심한 경우 뎅기출혈열이나 뎅기쇼크 증후군으로 진행되어 사망에 달할 수도 있습니다. 뎅기열에 대한 정확한 검사는 적절한 임상적 관리뿐만 아니라 질병의 확산을 막기 위해서도 매우 중요합니다. 조기 진단은 증상을 보다 효과적으로 관리하고 더 심각한 형태로의 진행을 억제하는 데 도움이 될 수 있습니다. 또한 유행 지역에서 뎅기열을 다른 발열성 질환과 구별하는 것은 공중보건 대응과 효율적인 자원 배분을 위해 필수적입니다.

뎅기열 검사는 어떻게 이루어지며, 어떤 기술이 관련되어 있는가?

뎅기열 검사에는 질병 단계에 따라 여러 가지 조사 방법이 있습니다. 초기에는 특이도가 높고 바이러스 혈청형을 확인할 수 있는 RT-PCR 검사로 바이러스 RNA를 검출할 수 있습니다. 질병이 진행됨에 따라 IgM 항체와 IgG 항체를 구별할 수 있는 ELISA(효소 결합 면역 흡착 분석법) 검사로 항체 검출에 초점을 맞추게 되는데, IgM 항체는 일반적으로 증상 발현 후 약 5일 후부터 검출이 가능하여 최근 감염을 나타내는 반면, IgG 항체는 그 이후에 나타나며 과거 감염이나 다른 혈청형에 의한 이차 감염에 의해 강화될 수 있습니다.에 의한 2차 감염에 의한 증강을 나타낼 수 있습니다. 신속진단검사(RDT)도 개발되어 있으며, 일반적으로 임상 검사에 기반한 검사보다 특이도는 떨어지지만, 사용의 용이성과 신속성으로 인해 자원이 제한된 환경에서 귀중한 검사법이 되고 있습니다.

뎅기열 검사의 과제는?

진단 기술의 발전에도 불구하고 뎅기열 검사는 여전히 큰 문제에 직면해 있습니다. 가장 큰 문제 중 하나는 지카, 치쿤구니야열 등 다른 플라비 바이러스와의 교차 반응성으로 오진을 유발할 수 있다는 점입니다. 이러한 바이러스가 공존하는 지역에서는 특히 문제가 될 수 있습니다. 또 다른 문제는 특히 신속 진단 검사의 민감도와 특이도가 다양하여 위음성 및 위양성을 유발할 수 있다는 점입니다. 이러한 부정확성은 환자 치료와 질병 감시에 심각한 영향을 미칠 수 있습니다. 또한 바이러스와 항체를 검출할 수 있는 기간이 비교적 짧기 때문에 적시에 검사가 필요하지만, 외딴 지역이나 서비스가 충분하지 않은 지역에서는 반드시 실행 가능한 것은 아닙니다. 이러한 문제들은 뎅기열 검사의 정확성, 접근성 및 신뢰성을 높이기 위한 지속적인 연구개발의 필요성을 강조하고 있습니다.

뎅기열 검사 시장의 성장을 가속하는 요인은 무엇인가?

뎅기열 검사 시장의 성장은 전 세계 뎅기열 발병률 증가를 비롯한 여러 요인에 기인합니다. 전 세계 여행객 증가와 모기 번식에 적합한 기후 조건으로 인해 뎅기열은 기존의 지역적 경계를 넘어 확장되고 있으며, 이에 따라 진단 검사에 대한 수요가 증가하고 있습니다. 뎅기열의 확산을 억제하는 데 중점을 둔 공중보건 노력은 특히 발병 국가에서 더 엄격한 감시 및 통제 조치를 시행하고 있는 상황에서 이러한 수요를 더욱 촉진하고 있습니다. 바이오테크놀러지의 발전으로 보다 신속하고 정확하며 비용 효율적인 검사가 개발되고 있는 것도 큰 성장 요인으로 작용하고 있습니다. 또한 뎅기열의 경제적, 건강상의 영향에 대한 인식이 높아지면서 예방 의료 및 진단에 대한 공공 및 민간 부문의 투자가 확대되고 있습니다. 마지막으로 COVID-19 팬데믹은 전염병에 대한 전 세계의 관심을 높이고 적시에 정확한 검사의 중요한 역할을 인식시켜 뎅기열 진단 분야에 대한 투자와 기술 혁신을 더욱 가속화했습니다. 이러한 기술적, 경제적, 사회적 촉진요인은 뎅기열 및 기타 매개 질환을 보다 효과적으로 관리하기 위한 공중 보건 인프라 개선에 대한 관심이 높아지면서 시장의 견고한 성장을 보장하고 있습니다.

조사 대상 기업의 예(주목 12사)

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 24.09.12

Global Dengue Testing Market to Reach US$740.8 Million by 2030

The global market for Dengue Testing estimated at US$531.0 Million in the year 2023, is expected to reach US$740.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$143.3 Million While China is Forecast to Grow at 8.3% CAGR

The Dengue Testing market in the U.S. is estimated at US$143.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Dengue Testing Market - Key Trends and Drivers Summarized

What Is Dengue and Why Is Accurate Testing Crucial?

Dengue fever is a mosquito-borne viral disease prevalent primarily in tropical and subtropical climates worldwide, posing significant public health challenges. Caused by one of the four dengue virus serotypes, it presents a wide range of symptoms from mild fever to severe flu-like conditions, and in critical cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be fatal. Accurate testing for dengue is crucial not only for appropriate clinical management but also for controlling the spread of the disease. Early diagnosis helps in managing the symptoms more effectively and can reduce the progression to more severe forms. Moreover, distinguishing dengue from other febrile illnesses in endemic regions is essential for targeted public health responses and efficient resource allocation.

How Are Dengue Tests Conducted and What Technologies Are Involved?

Dengue testing involves several methodologies that depend on the stage of the illness. In the early stages, viral RNA can be detected using RT-PCR tests, which are highly specific and can identify the virus serotype. As the disease progresses, the focus shifts to detecting antibodies using ELISA (enzyme-linked immunosorbent assay) tests that can differentiate between IgM and IgG antibodies. IgM antibodies are typically detectable from about five days after the onset of symptoms and indicate a recent infection, while IgG antibodies appear later and can indicate a past infection or enhancement due to secondary infection with a different serotype. Rapid diagnostic tests (RDTs) have also been developed, which are invaluable in resource-limited settings for their ease of use and quick turnaround times, although they generally offer less specificity than laboratory-based tests.

What Are the Challenges in Dengue Testing?

Despite advances in diagnostic technologies, dengue testing faces significant challenges. One major issue is the cross-reactivity with other flaviviruses such as Zika and chikungunya, which can lead to misdiagnosis. This is particularly problematic in regions where these viruses co-circulate. Another challenge is the variation in test sensitivity and specificity, especially among rapid diagnostic tests, which can lead to false negatives or false positives. Such inaccuracies can have severe implications for patient care and disease surveillance. Additionally, the window for detecting the virus or antibodies is relatively short, which necessitates timely testing that may not always be feasible in remote or underserved areas. These challenges underscore the need for ongoing research and development to enhance the accuracy, accessibility, and reliability of dengue testing methods.

What Drives the Growth in the Dengue Testing Market?

The growth in the dengue testing market is driven by several factors, beginning with the rising incidence of dengue worldwide. As global travel increases and climatic conditions favor mosquito breeding, dengue is expanding beyond traditional geographic boundaries, increasing the demand for diagnostic tests. Public health initiatives focused on controlling the spread of dengue also fuel this demand, particularly in endemic countries that are implementing more rigorous surveillance and control measures. Advances in biotechnology that have led to the development of faster, more accurate, and cost-effective tests are also significant growth drivers. Additionally, the growing awareness of the economic and health impacts of dengue has led to greater public and private sector investment in preventive care and diagnostics. Finally, the COVID-19 pandemic has heightened global attention on infectious diseases and the critical role of timely and accurate testing, further accelerating investment and innovation in the field of dengue diagnostics. These technological, economic, and social drivers ensure robust market growth, reflecting an increasing emphasis on improving public health infrastructure to manage dengue and other vector-borne diseases more effectively.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories, Inc.
  • Abnova Corporation
  • Certest Biotec S.L.
  • Euroimmun AG
  • InBios International
  • NovaTec Immundiagnostica GmbH
  • OriGene Technologies, Inc.
  • Quest Diagnostics, Inc.
  • Roche Molecular Systems Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Dengue Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Dengue Fever Drives Demand for Effective Testing Solutions
    • Growing Public Health Initiatives to Combat Dengue Bolster Testing Market
    • Technological Advancements in Diagnostic Kits Enhance Rapid and Accurate Dengue Detection
    • Expansion of Healthcare Infrastructure in Endemic Regions Spurs Market Growth
    • Increasing Travel and Migration Amplify Risks and Demand for Dengue Testing
    • Expansion of Laboratory and In-Clinic Testing Capacities in Developing Countries
    • Increasing Use of Point-of-Care Testing Devices for Dengue in Remote Areas
    • Rising Demand for Molecular Diagnostic Tests for Early Dengue Detection
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for ELISA-Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR Based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for RT-PCR Based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Dengue IgG / IgM Rapid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Dengue Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dengue Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Dengue Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Dengue Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Dengue Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Dengue Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Dengue Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Dengue Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Dengue Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Dengue Testing by End-Use - Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Dengue Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Public Health Laboratory and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제